A meta-analysis of studies reporting outcomes for women treated for stage IVA reports roughly one-third are still alive at 5 years with death largely driven by local failures suggesting outcomes hinge on achieving adequate local control with concurrent chemoradiation and brachytherapy despite treatment conferring a 25% rate of vaginal fistula. | Kumar Saini, Int J Radiat Oncol Biol Phys 2026
